CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat

被引：0
作者：
Styliani Vlachou
George G. Nomikos
George Panagis
机构：
[1] University of Crete,Laboratory of Behavioral Neuroscience, Department of Psychology, School of Social Sciences
[2] Eli Lilly and Company,Neuroscience Research, Lilly Corporate Center
来源：
Psychopharmacology | 2005年 / 179卷
关键词：
Intracranial self-stimulation; Cannabinoid; Medial forebrain bundle; Reward; WIN 55,212-2; CP 55,940; HU-210; SR141716A; AM 251;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：498 / 508
页数：10
相关论文
共 50 条
  • [31] Role of μ-opioid receptor reserve and μ-agonist efficacy as determinants of the effects of μ-agonists on intracranial self-stimulation in rats
    Altarifi, Ahmad A.
    Miller, Laurence L.
    Negus, S. Stevens
    BEHAVIOURAL PHARMACOLOGY, 2012, 23 (07): : 678 - 692
  • [32] Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor
    Garcia, DE
    Brown, S
    Hille, B
    Mackie, K
    JOURNAL OF NEUROSCIENCE, 1998, 18 (08) : 2834 - 2841
  • [33] Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents
    Wade, Mark R.
    Degroot, Aldemar
    Nomikos, George G.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 551 (1-3) : 162 - 167
  • [34] The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus
    Takahashi, K. A.
    Castillo, P. E.
    NEUROSCIENCE, 2006, 139 (03) : 795 - 802
  • [35] Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization
    Jin, WZ
    Brown, S
    Roche, JP
    Hsieh, C
    Celver, JP
    Kovoor, A
    Chavkin, C
    Mackie, K
    JOURNAL OF NEUROSCIENCE, 1999, 19 (10) : 3773 - 3780
  • [36] Discovery of indole alkaloids with cannabinoid CB1 receptor antagonistic activity
    Kitajima, Mariko
    Iwai, Masumi
    Kikura-Hanajiri, Ruri
    Goda, Yukihiro
    Iida, Mitsuru
    Yabushita, Hisatoshi
    Takayama, Hiromitsu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 1962 - 1964
  • [37] Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease
    González, S
    Scorticati, C
    García-Arencibia, M
    de Miguel, R
    Ramos, JA
    Fernández-Ruiz, J
    BRAIN RESEARCH, 2006, 1073 : 209 - 219
  • [38] Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists
    Amato, George S.
    Manke, Amruta
    Vasukutta, Vineetha
    Wiethe, Robert W.
    Snyder, Rodney W.
    Runyon, Scott P.
    Maitra, Rangan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (15) : 4518 - 4531
  • [39] Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes
    Wang, SJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 469 (1-3) : 47 - 55
  • [40] Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist
    Amaya, Fumimasa
    Shimosato, Goshun
    Kawasaki, Yasuhiko
    Hashimoto, Satoru
    Tanaka, Yoshifumi
    Ji, Ru-Rong
    Tanaka, Masaki
    PAIN, 2006, 124 (1-2) : 175 - 183
12345